Sera Prognostics, Inc.

NASDAQ:SERA

4.07 (USD) • At close March 14, 2025
Bedrijfsnaam Sera Prognostics, Inc.
Symbool SERA
Munteenheid USD
Prijs 4.07
Beurswaarde 138,602,629
Dividendpercentage 0%
52-weken bereik 3.84 - 12.355
Industrie Diagnostics & Research
Sector Healthcare
CEO Ms. Evguenia Lindgardt M.B.A.
Website https://seraprognostics.com

An error occurred while fetching data.

Over Sera Prognostics, Inc.

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various

Vergelijkbare Aandelen

BeyondSpring Inc. logo

BeyondSpring Inc.

BYSI

1.741 USD

ProQR Therapeutics N.V. logo

ProQR Therapeutics N.V.

PRQR

1.69 USD

MiNK Therapeutics, Inc. logo

MiNK Therapeutics, Inc.

INKT

8.488 USD

Freeline Therapeutics Holdings plc logo

Freeline Therapeutics Holdings plc

FRLN

6.49 USD

BioSig Technologies, Inc. logo

BioSig Technologies, Inc.

BSGM

0.614 USD

Corvus Pharmaceuticals, Inc. logo

Corvus Pharmaceuticals, Inc.

CRVS

4.52 USD

Syros Pharmaceuticals, Inc. logo

Syros Pharmaceuticals, Inc.

SYRS

0.092 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)